<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Immix Biopharma's expenses impact Q4 2024 revenue?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 05:34pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Immix Biopharma's expenses had a significant impact on the company's Q4 2024 revenue. The company reported total operating expenses and other expenses, but the specific values were not provided. However, the total revenue for the quarter was $4.8 million. This indicates that the company's expenses were substantial, as they exceeded the revenue generated during the period. 


</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac){return {layout:"default",data:[{noData:c,currentQuestion:e,textDescription:E,comeFrom:"AInvestShareLink",events:[],answerSource:i}],fetch:{},error:j,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:k,agent_id:a,output_media_info:[],task_id:a,language:a,source:i,cache_builder:a,reply_action:"Answer",execute_mode:x,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Immix Biopharma's expenses impact Q4 2024 revenue?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Immix Biopharma's expenses impact Q4 2024 revenue?\",\"user_id\":\"dp85970118\",\"user_name\":\"\",\"trace_id\":\"fae24670-8115-4ed3-9956-45dddae0fd19\",\"session_id\":\"fae24670-8115-4ed3-9956-45dddae0fd19\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:y,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue[20241231]|Total Operating Expenses[20241231]|Total Other Expenses[20241231]|\n|---|---|---|---|---|---|---|\n|IMMX|Immix Biopharma|$2.12|8.72%||$4.8 million||\n",query_data:{number:k,title:z,query_type:y,condition:a,model_sql:F,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:f}}}],answer_chain_name:G,agent_mode:H,native_answer:a,come_from:a,text_answer:E,trace_id:g,cost:16221,event_names:a,question:e,fallback_type:I,input_type:J,fall_back_reason:{fall_back_type:I,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:g,first_return_cost:2761,cache_type:"no_cache",question_id:g,transfer_question:e,signal_type:"ON_COMPLETE",start_time:A,remote_svc:i,slots:[],answer_type:x,user_id:p,skill_name:B},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:g,session_id:g,user_id:p,question:e,source:i,raw_question:e,version:"3.4.1",action_name:B,nlu:{entity:[{type:K,value:"IMMX.O",market:L}]},output_time:A,deep_research:c,deep_thinking:c,agent_mode:H},extra:{}},{answer_path:q,section:{id:r,info_texts:["Thinking"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:q,section:{id:r,info_texts:["Querying Stock: IMMX Revenue, Operating Expenses, Other Expenses in Fiscal 2024 Q4"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:z,thought:"The user wants to know how Immix Biopharma's expenses impacted its Q4 2024 revenue. I should focus on the company's Q4 2024 revenue, operating expenses, and other expense data. I will use FinQuery for the data mentioned above."}},{answer_path:d,section:{id:l,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:q,section:{id:r,info_texts:["Generating Answer"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:t,info_texts:[],show_type:u,voice_txt:"Im",text_answer:M,rich_text:M,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:u,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:z,query_type:y,trace_data:a,index:k,model_sql:F,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:f},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:t,info_texts:[],show_type:u,voice_txt:". This",text_answer:N,rich_text:N,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"IMMX",market_id:L,name:O,domain:K},pos:f,section_id:t,txt:O,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:t,info_texts:[],show_type:u,voice_txt:"\n",text_answer:P,rich_text:P,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:q,section:{id:r,info_texts:["Completed"],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:m,query_text:m,trace_info:{item_id:"9b3173d257adfdea7da84feed274cdf6",item_type:v,item_name:m,rec_info:Q}},{display_text:n,query_text:n,trace_info:{item_id:"ef94b58eb11e85a8fd7d727c4cec0bf6",item_type:v,item_name:n,rec_info:R}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:f,type:"1",display2:c,url:a}},request_config:[{source_type:3,related_name:S}],puuid:C,tag:a,category:"custom",uuid:T}],global:{urp_static_data:[{name:S,value:{status_code:f,columns:[{type:o,index_name:U,key:U},{type:o,index_name:V,key:V},{type:o,index_name:W,key:W},{type:o,index_name:X,key:X},{type:o,index_name:Y,key:Y}],datas:[{send_text:m,item_type:v,rec_info:Q,display_text:m,rec_reason:a},{send_text:n,item_type:v,rec_info:R,display_text:n,rec_reason:a}],dataSize:2,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:Z,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:w,"min-height":"100%",position:_,height:w},isMaterial:c,id:Z,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:D,componentUuid:T,script:[{name:$,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:D,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:D},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:w,position:_,height:w},isMaterial:b,_id:19,id:$,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:aa,voice_txt:a,tracking_info:{},uuid:C},order:{is_auto:c,render_for:aa,chart_type:"command",puuid:C}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:h,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:B,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:x,answer_chain_name:G},is_deep_research:c,deep_thinking:c,create_time:1746696915982},is_last:b}],questionItem:{data:{qStr:e,encodeFlag:c,imageData:j,docsData:[],quoteData:j},tplType:"question"},events:ab,agentId:a,param:{entity_info:{},add_info:{ori_question:e},event_list:ab,client_ip:a,question:e,user_id:p,user_name:a,trace_id:g,session_id:g,source:i,input_type:J}}],userId:p,userName:a,startTime:A,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:j,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:f,traceTableData:j,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-immix-biopharmas-expenses-impact-q4-2024-revenue-3067d6\u002F",config:{_app:{basePath:ac,assetsPath:ac,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer","How did Immix Biopharma's expenses impact Q4 2024 revenue?",0,"fae24670-8115-4ed3-9956-45dddae0fd19","signal","ths_ainvest_lite_web",null,1,999,"How did Immix Biopharma's cost of goods sold affect Q4 2024 revenue?\n\u003C|im_end|\u003E","Were there any significant changes in Immix Biopharma's operating costs in Q4 2024?","STR","dp85970118","progress\u002Fsearching_for",1000,"searching_for",2001,"rich_text","llm_generated","auto","agent","intusstock","IMMX Revenue, Operating Expenses, Other Expenses in Fiscal 2024 Q4",1746696899761,"explain news events","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Immix Biopharma's expenses had a significant impact on the company's Q4 2024 revenue. The company reported total operating expenses and other expenses, but the specific values were not provided. However, the total revenue for the quarter was $4.8 million. This indicates that the company's expenses were substantial, as they exceeded the revenue generated during the period. \n\n\n","select   stock_code,   total_revenue,   total_operating_expenses,   total_other_expenses from   ustock_fin_data where   fiscal_date = date('2024y4q')   and stock_code = 'IMMX.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","186","Immix Biopharma's expenses had a significant impact on the company's Q4 2024 revenue. The company reported total operating expenses and other expenses, but the specific values were not provided. However, the total revenue for the quarter was $4.8 million[^1]",". This indicates that the company's expenses were substantial, as they exceeded the revenue generated during the period. \n\n","Immix Biopharma","\n``` visual\n{\"uuid\":\"22f9c824-908f-48a1-9f82-f845ce44c0b4\"}\n```","2+679_496_21_554+0+0+fae24670-8115-4ed3-9956-45dddae0fd19+9b3173d257adfdea7da84feed274cdf6+llm_generated+aimeTagAnalysis+0+0.03128627687692642+1","2+679_496_21_554+0+0+fae24670-8115-4ed3-9956-45dddae0fd19+ef94b58eb11e85a8fd7d727c4cec0bf6+llm_generated+aimeTagAnalysis+0+0.026002520695328712+2","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>